Anemia, Bone Density Improve With Testosterone Replacement
Older men on TRT versus placebo for 1 year had improved hemoglobin levels and volumetric bone mineral density and estimated bone strength.
Diagnosis & Disease Information
Testosterone Replacement May Lower Cardiovascular Risks
In a large study, testosterone replacement therapy was associated with a 33% lower risk of cardiac and stroke events among hypogonadal men.
Normal Testosterone Range Defined
The normal range for total testosterone is 264 to 916 ng/dL for healthy men ages 19 to 39 with a body mass index below 30 kg/m2.
Venous Thromboembolism Risk Up in TRT Initiators
Risk peaks in the first 6 months of hormone treatment, but overall odds are low.
2 Percent Daily Testosterone Shows 6-Month Efficacy
Once-daily T-sol administered for 6 months did not indicate new safety concerns, and the outcomes of low sex drive and low energy showed further improvement.
FDA Adds Abuse Warning to All Testosterone Products
The new FDA warning alerts prescribers to the abuse potential of testosterone.
FDA Adds New Testosterone Warnings
Labeling changes will alert prescribers to the abuse potential of testosterone and the serious adverse effects.
TRT May Improve Cognition in Younger Hypogonadal Men
Young men reported improvement in executive function after 2 years of TRT.
Study: mpMRI Findings in Prostate Cancer Patients Unaffected by TRT
Results show that mpMRI and PI-RADSv2 score have a greater ability to detect prostate cancer progression after TRT compared with PSA.
Testosterone Solution Effective for Hypogonadism Over 9 Months
Once-daily 2% testosterone solution safe and effective for sex drive and energy.
- Loading...
Loading...
Next post in Hypogonadism
Loading... 
Loading...